SARTORIUS AG UNSP.ADR 1/5 (SRT4) - Total Liabilities
Based on the latest financial reports, SARTORIUS AG UNSP.ADR 1/5 (SRT4) has total liabilities worth €5.98 Billion EUR (≈ $6.99 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore how fast is SARTORIUS AG UNSP.ADR 1/5 growing its equity to track the company's year-over-year net asset growth rate.
SARTORIUS AG UNSP.ADR 1/5 - Total Liabilities Trend (2021–2025)
This chart illustrates how SARTORIUS AG UNSP.ADR 1/5's total liabilities have evolved over time, based on quarterly financial data.
SARTORIUS AG UNSP.ADR 1/5 Competitors by Total Liabilities
The table below lists competitors of SARTORIUS AG UNSP.ADR 1/5 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shandong Sinocera Func Material
SHE:300285
|
China | CN¥2.24 Billion |
|
PSP SWISS ADR 1/5/SF1050
F:P7S0
|
Germany | €4.53 Billion |
|
AAK AB
ST:AAK
|
Sweden | Skr12.65 Billion |
|
Telekom Malaysia Bhd
KLSE:4863
|
Malaysia | RM9.70 Billion |
|
Konfoong Materials International Co Ltd
SHE:300666
|
China | CN¥6.84 Billion |
|
Kingfa Sci&Tech Co Ltd
SHG:600143
|
China | CN¥42.31 Billion |
|
Xp Inc
NASDAQ:XP
|
USA | $375.81 Billion |
|
Shenyang Fortune Precision Equipment Co. Ltd. A
SHG:688409
|
China | CN¥4.39 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down SARTORIUS AG UNSP.ADR 1/5's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is SARTORIUS AG UNSP.ADR 1/5 worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SARTORIUS AG UNSP.ADR 1/5's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SARTORIUS AG UNSP.ADR 1/5 (2021–2025)
The table below shows the annual total liabilities of SARTORIUS AG UNSP.ADR 1/5 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €5.85 Billion ≈ $6.84 Billion |
-5.73% |
| 2024-12-31 | €6.21 Billion ≈ $7.25 Billion |
-11.20% |
| 2023-12-31 | €6.99 Billion ≈ $8.17 Billion |
+61.79% |
| 2022-12-31 | €4.32 Billion ≈ $5.05 Billion |
+8.58% |
| 2021-12-31 | €3.98 Billion ≈ $4.65 Billion |
-- |
About SARTORIUS AG UNSP.ADR 1/5
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management pro… Read more